Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026)

Insulet (PODD) posted Liabilities and Shareholders Equity of $3.0 billion for Q1 2026, down 6.37% on a QoQ basis from $3.2 billion in Q4 2025, and down 15.07% year-over-year from $3.5 billion in Q1 2025.

Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Insulet's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 15.07% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.7 billion (up 1.31% YoY) and the FY2025 annual result came in at $3.2 billion, up 3.33% from the prior year.
  • Liabilities and Shareholders Equity was $3.0 billion for Q1 2026 at Insulet, down from $3.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.5 billion in Q1 2025 and bottomed at $2.1 billion in Q1 2022.
  • A 5-year average of $2.7 billion and a median of $2.6 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 34.04% — and 2026, when it decreased 15.07%.
  • Insulet's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then increased by 14.97% to $2.6 billion in 2023, then rose by 19.3% to $3.1 billion in 2024, then grew by 3.33% to $3.2 billion in 2025, then decreased by 6.37% to $3.0 billion in 2026.
  • Business Quant data shows PODD's Liabilities and Shareholders Equity at $3.0 billion in Q1 2026, $3.2 billion in Q4 2025, and $3.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 10.46 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 31.92 Bn
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn 2.99 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.99 Bn
Dec 31, 2025 3.19 Bn
Sep 30, 2025 3.03 Bn
Jun 30, 2025 3.47 Bn
Mar 31, 2025 3.52 Bn
Dec 31, 2024 3.09 Bn
Sep 30, 2024 3.03 Bn
Jun 30, 2024 2.88 Bn
Mar 31, 2024 2.62 Bn
Dec 31, 2023 2.59 Bn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 2.39 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.25 Bn
Sep 30, 2022 2.17 Bn
Jun 30, 2022 2.11 Bn
Mar 31, 2022 2.07 Bn
Dec 31, 2021 2.05 Bn
Sep 30, 2021 2.00 Bn
Jun 30, 2021 1.92 Bn